Ocean Biomedical, Inc. (OCEA)
NASDAQ: OCEA · IEX Real-Time Price · USD
1.440
-0.040 (-2.70%)
Apr 24, 2024, 10:56 AM EDT - Market open
Ocean Biomedical Market Cap
Ocean Biomedical has a market cap or net worth of $49.55 million as of April 24, 2024. Its market cap has decreased by -78.36% in one year.
Market Cap
49.55M
Enterprise Value
61.61M
1-Year Change
-78.36%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since September 15, 2021, Ocean Biomedical's market cap has decreased from $126.80M to $49.55M, a decrease of -60.92%. That is a compound annual growth rate of -30.28%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 50.50M | -1.75% |
Apr 22, 2024 | 51.40M | -14.48% |
Apr 19, 2024 | 60.10M | -6.09% |
Apr 18, 2024 | 64.00M | 4.92% |
Apr 17, 2024 | 61.00M | -0.16% |
Apr 16, 2024 | 61.10M | -5.86% |
Apr 15, 2024 | 64.90M | -14.83% |
Apr 12, 2024 | 76.20M | 1.46% |
Apr 11, 2024 | 75.10M | -9.30% |
Apr 10, 2024 | 82.80M | -1.66% |
Apr 9, 2024 | 84.20M | -4.97% |
Apr 8, 2024 | 88.60M | -1.66% |
Apr 5, 2024 | 90.10M | -1.74% |
Apr 4, 2024 | 91.70M | -8.48% |
Apr 3, 2024 | 100.20M | -7.22% |
Apr 2, 2024 | 108.00M | -11.98% |
Apr 1, 2024 | 122.70M | -4.88% |
Mar 28, 2024 | 129.00M | -6.72% |
Mar 27, 2024 | 138.30M | -0.29% |
Mar 26, 2024 | 138.70M | -2.87% |
Mar 25, 2024 | 142.80M | -1.18% |
Mar 22, 2024 | 144.50M | -4.93% |
Mar 21, 2024 | 152.00M | -3.86% |
Mar 20, 2024 | 158.10M | 3.33% |
Mar 19, 2024 | 153.00M | 10.87% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
HeartBeam | 53.71M |
DIH Holdings US | 53.31M |
ARCA biopharma | 52.93M |
XORTX Therapeutics | 52.89M |
Eledon Pharmaceuticals | 52.27M |
American Oncology Network | 50.91M |
BioLineRx | 50.91M |
Checkpoint Therapeutics | 50.21M |